OPHLF
Price:
$14.55
Market Cap:
$1.06T
Globally, Ono Pharmaceutical Co., Ltd., along with its affiliated entities, is engaged in the development, procurement, and commercialization of pharmaceutical products and diagnostic tools. Its product line features a wide array of therapeutic solutions, including several key oncology treatments such as OPDIVO, KYPROLIS, MEKTOVI, VELEXBRU, ADLUMIZ, and BRAFTOVI. It also offers EMEND and PROEMEND for managing chemotherapy-induced nausea and vomiting, and DEMSER for pheochromocytoma symptoms. For metabolic health, GLACTIV and FORXIGA target type 2 diabetes. The company provides medications for cardiovascular conditions (ONOACT for tachyarrhythmia, OPALMON for peripheral circulatory disorder, ...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2013-03-21
Stock Exchange
OTC
Ticker
OPHLF
According to Ono Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 15.65. This represents a change of -83.90% compared to the average of 97.21 of the last 4 quarters.
The mean historical PE Ratio of Ono Pharmaceutical Co., Ltd. over the last ten years is 18.98. The current 15.65 PE Ratio has changed 8.14% with respect to the historical average. Over the past ten years (40 quarters), OPHLF's PE Ratio was at its highest in in the March 2026 quarter at 360.70. The PE Ratio was at its lowest in in the March 2025 quarter at -28.76.
Average
18.98
Median
19.01
Minimum
9.26
Maximum
33.96
Discovering the peaks and valleys of Ono Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 62.44%
Maximum Annual PE Ratio = 33.96
Minimum Annual Increase = -78.35%
Minimum Annual PE Ratio = 9.26
| Year | PE Ratio | Change |
|---|---|---|
| 2026 | 16.91 | 12.41% |
| 2025 | 15.04 | 62.44% |
| 2024 | 9.26 | -22.67% |
| 2023 | 11.97 | -36.66% |
| 2022 | 18.90 | -1.16% |
| 2021 | 19.13 | -8.86% |
| 2020 | 20.98 | -3.74% |
| 2019 | 21.80 | -35.80% |
| 2018 | 33.96 | 55.12% |
| 2017 | 21.89 | -78.35% |
The current PE Ratio of Ono Pharmaceutical Co., Ltd. (OPHLF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
13.74
5-year avg
14.42
10-year avg
18.98
Ono Pharmaceutical Co., Ltd.’s PE Ratio is greater than Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (11.42), greater than H. Lundbeck A/S (11.15), less than Santen Pharmaceutical Co., Ltd. (16.43), greater than Hikma Pharmaceuticals PLC (0.18), greater than Hikma Pharmaceuticals PLC (0.18), less than Kyowa Kirin Co., Ltd. (18.22), greater than H. Lundbeck A/S (11.15), greater than DiaSorin S.p.A. (14.62), less than Fielmann AG (17.88), less than Raia Drogasil S.A. (21.20),
| Company | PE Ratio | Market cap |
|---|---|---|
| 11.42 | $6.20B | |
| 11.15 | $5.23B | |
| 16.43 | $3.54B | |
| 0.18 | $4.08B | |
| 0.18 | $4.13B | |
| 18.22 | $7.55B | |
| 11.15 | $5.84B | |
| 14.62 | $3.69B | |
| 17.88 | $4.26B | |
| 21.20 | $5.72B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ono Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ono Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Ono Pharmaceutical Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Ono Pharmaceutical Co., Ltd. (OPHLF)?
What is the highest PE Ratio for Ono Pharmaceutical Co., Ltd. (OPHLF)?
What is the 3-year average PE Ratio for Ono Pharmaceutical Co., Ltd. (OPHLF)?
What is the 5-year average PE Ratio for Ono Pharmaceutical Co., Ltd. (OPHLF)?
How does the current PE Ratio for Ono Pharmaceutical Co., Ltd. (OPHLF) compare to its historical average?